Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Interest Expenses (2023 - 2025)

Arcus Biosciences has reported Interest Expenses over the past 3 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Interest Expenses at $2.0 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $8.0 million (up 100.0% YoY), and the annual figure for FY2025 was $8.0 million, up 100.0%.
  • Interest Expenses for Q4 2025 was $2.0 million at Arcus Biosciences, down from $3.0 million in the prior quarter.
  • Over the last five years, Interest Expenses for RCUS hit a ceiling of $3.0 million in Q3 2025 and a floor of $1.0 million in Q3 2023.
  • Median Interest Expenses over the past 3 years was $1.5 million (2023), compared with a mean of $1.6 million.
  • Biggest five-year swings in Interest Expenses: changed 0.0% in 2024 and later skyrocketed 200.0% in 2025.
  • Arcus Biosciences' Interest Expenses stood at $1.0 million in 2023, then skyrocketed by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • The last three reported values for Interest Expenses were $2.0 million (Q4 2025), $3.0 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.